This inventor holds 3 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 2 EPO patents. Top assignees: Excelsior Pharmatech Labs, China Medical University, Kaohsiung Chang Gung Memorial Hospital. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3 
1 out of 110 
1 out of 12 Years Active: 2019-2023
Title: Hsien-Yuan Lane: Innovator in Mental Health Solutions
Introduction
Hsien-Yuan Lane is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of mental health through his innovative approaches to treatment. With a total of 3 patents, Lane's work focuses on the therapeutic applications of benzoic acid and its derivatives.
Latest Patents
Lane's latest patents include a method for preventing or treating depression using benzoic acid or its salts. This patent outlines a method that involves administering an effective amount of benzoic acid to individuals in need of treatment. Additionally, he has developed a method for preventing or treating autism spectrum disorders through the use of benzoic acid salts. This method specifies the administration of a therapeutically effective amount of benzoic acid salt, ranging from 100 mg/day to 2000 mg/day.
Career Highlights
Throughout his career, Hsien-Yuan Lane has worked with various companies, including Excelsior Pharmatech Labs. His innovative research has positioned him as a key figure in the development of new therapeutic methods for mental health conditions.
Collaborations
Lane has collaborated with notable individuals in his field, including Chieh-Hsin Lin. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Hsien-Yuan Lane's contributions to mental health treatment through his innovative patents highlight his dedication to improving the lives of individuals with depression and autism spectrum disorders. His work continues to pave the way for new therapeutic approaches in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile